SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001461790-22-000007
Filing Date
2022-01-18
Accepted
2022-01-18 17:33:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 MCADU_BTTX_13GA_20220118.htm SC 13G/A 104333
  Complete submission text file 0001461790-22-000007.txt   105943
Mailing Address 2 BLOOR STREET WEST SUITE 801 TORONTO A6 M4W 3E2
Business Address 2 BLOOR STREET WEST SUITE 801 TORONTO A6 M4W 3E2 416-365-2155
K2 PRINCIPAL FUND, L.P. (Filed by) CIK: 0001461790 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 311 WEST 43RD STREET, 12TH FLOOR NEW YORK NY 10036
Business Address 311 WEST 43RD STREET, 12TH FLOOR NEW YORK NY 10036 646-493-6558
Better Therapeutics, Inc. (Subject) CIK: 0001832415 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1028
Type: SC 13G/A | Act: 34 | File No.: 005-91979 | Film No.: 22536072
SIC: 8000 Services-Health Services